Cytokine storm

Cited by (1,002)

Items 801–900 of 1,002

1. Cytokine storm in human monkeypox: A possible involvement of purinergic signaling
   Gilnei Bruno da Silva, Geórgia de Carvalho Braga, Júlia Leão Batista Simões, Aniela Pinto Kempka, Margarete Dulce Bagatini · 2024 · Cytokine
2. Regulatory functions and mechanisms of human microbiota in infectious diseases
   Yingxu Fang, Zehui Lei, Lingqiang Zhang, Cui Hua Liu, Qiyao Chai · 2024 · hLife
3. Infection of domestic pigs with a genotype II potent strain of ASFV causes cytokine storm and lymphocyte mass reduction
   Xuezhi Zuo, Guorui Peng, Junjie Zhao, Qizu Zhao, Yuanyuan Zhu, Yuan Xu, Lu Xu, Fangtao Li, Yingju Xia, Yebing Liu et al. · 2024 · Frontiers in Immunology
4. siRNA Nanoparticle Dry Powder Formulation with High Transfection Efficiency and Pulmonary Deposition for Acute Lung Injury Treatment
   Rui Li Xu, Chenjie Xia, Xiongxiong He, Changhui Hu, Yinjia Li, Yufeng Zhang, Zhipeng Chen · 2024 · ACS Applied Materials & Interfaces
5. COVID-19 and HIV-Associated Immune Reconstitution Inflammatory Syndrome: Emergence of Pathogen-Specific Immune Responses Adding Fuel to the Fire
   Nabila Seddiki, Martyn A. French · 2021 · Frontiers in Immunology
6. The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-γ production in vitro
   Jinglu Lyu, Lirong Bao, Xin Shen, Caixia Yan, Cheng Zhang, Wei Wei, Yutao Yang, Jia Li, Jiajia Dong, Liying Xiao et al. · 2021 · International Immunopharmacology
7. Inflammasome regulation in driving COVID-19 severity in humans and immune tolerance in bats
   Sahana Nagaraja, Disha Jain, Sannula Kesavardhana · 2021 · Journal of Leukocyte Biology
8. Extracorporeal carbon dioxide removal with the Advanced Organ Support system in critically ill COVID‐19 patients
   Julia Allescher, Sebastian Rasch, Johannes Roman Wiessner, Aritz Pérez Ruiz de Garibay, Christina Huberle, Felix Hesse, Dominik Schulz, Roland Michael Schmid, Wolfgang Huber, Tobias Lahmer · 2021 · Artificial Organs
9. Cell death and pathological findings of the spleen in COVID-19 patients
   Haiqin Ping, Kai Zhang, Yunyun Wang, Xin Tong, Zhaojun Chen, Caiyun Cai, Zhiyan Lu, Xien Gui, Liang Liu, Xinghuan Wang et al. · 2021 · Pathology - Research and Practice
10. The COVID-19 pandemic — what have urologists learned?
    Benedikt Ebner, Yannic Volz, Jan‐Niclas Mumm, Christian Georg Stief, Giuseppe Magistro · 2022 · Nature Reviews Urology
11. RNA-guided cell targeting with CRISPR/RfxCas13d collateral activity in human cells
    Shi, Peiguo, Murphy, Michael R., Aparicio, Alexis O., Kesner, Jordan S., Fang, Zhou, Chen, Ziheng, Trehan, Aditi, Wu, Xuebing · 2021
12. The CXCL8/MAPK/hnRNP-K axis enables susceptibility to infection by EV-D68, rhinovirus, and influenza virus in vitro
    Qingran Yang, Haoran Guo, Huili Li, Zhaoxue Li, Fushun Ni, Zhongmei Wen, Kai Liu, Huihui Kong, Wei Wei · 2025 · Nature Communications
13. PANoptosis in Sepsis: A Central Role and Emerging Therapeutic Target
    Qiqi Wu, Siyuan Qi, Zhaofeng Kang, Xiangjun Bai, Zhanfei Li, Jing Cheng, Xijie Dong · 2025 · Journal of Inflammation Research
14. Nanomedicine and Spleen-Targeting Strategies for Precision Immunomodulation: Advances, Challenges, and Future Perspectives
    Chiwoo Oh, Ho Sun Jung, Jiwoo Park, J. Awad, Dawei Jiang, David J. Dowling, Hyung‐Jun Im · 2025 · ACS Nano
15. Targeting PANoptosis: a promising therapeutic strategy for ALI/ARDS
    Mengqi Zhang, Luorui Shang, Fangyuan Zhou, Yuju Cai, Shuhan Wang, Jinxiao Li, Yuhan Liu, Jianghua Huang, Shenglan Yang · 2025 · APOPTOSIS
16. Precision cytokine modulation to overcome tumor microenvironment-driven resistance to immune checkpoint blockade
    Xiaodong Wang, Junjie Wang, Qianqian Wang, Gouping Ding, Yiping Huang, Yeqian Feng · 2026 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
17. Identification and Development of Therapeutics for COVID-19
    Halie M. Rando, Nils Wellhausen, Soumita Ghosh, Alexandra J. Lee, Anna Ada Dattoli, Fengling Hu, James Brian Byrd, Diane N. Rafizadeh, Ronan Lordan, Yanjun Qi et al. · 2021 · mSystems
18. Corticosteroids in SARS-COV2 infection: certainties and uncertainties in clinical practice
    Radu Adrian Crișan-Dabija, Ileana Antohe, Antigona Carmen Trofor, Sabina A Antoniu · 2021 · Expert Review of Anti-infective Therapy
19. Electrochemical Nanobiosensors as Point‐of‐Care Testing Solution to Cytokines Measurement Limitations
    David J. Pérez, Edwin Patiño, Jahir Orozco · 2021 · Electroanalysis
20. Case Report: C-Reactive Protein Apheresis in a Patient With COVID-19 and Fulminant CRP Increase
    Jens Ringel, Anja Ramlow, Christopher Bock, Ahmed Sheriff · 2021 · Frontiers in Immunology
21. Prior Immunosuppressive Therapy and Severe Illness Among Patients Diagnosed with SARS-CoV-2: a Community-Based Study
    Fernando S. Velayos, Jennifer R. Dusendang, Julie A. Schmittdiel · 2021 · Journal of General Internal Medicine
22. IL-18: The Forgotten Cytokine in Dengue Immunopathogenesis
    Josephine Diony Nanda, Tzong‐Shiann Ho, Rahmat Dani Satria, Ming-Kai Jhan, Yung-Ting Wang, Chiou‐Feng Lin · 2021 · Journal of Immunology Research
23. Colchicine Against SARS-CoV-2 Infection: What is the Evidence?
    Alexandros A. Drosos, Eleftherios Pelechas, Vassiliki Drossou, Paraskevi V. Voulgari · 2022 · Rheumatology and Therapy
24. The elimination of circulating Epstein-Barr virus infected B cells underlies anti-CD20 monoclonal antibody activity in multiple sclerosis: A hypothesis
    Joseph R. Berger, Mihir Kakara · 2022 · Multiple Sclerosis and Related Disorders
25. Effects of non‐steroidal anti‐inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID‐19
    Milena Sokołowska, G. Enrico Rovati, Zuzana Diamant, Eva Untersmayr, Jürgen Schwarze, Zuzanna Małgorzata Łukasik, Florentina Sava, Alba Angelina, Óscar Palomares, Cezmi A. Akdiş et al. · 2022 · Allergy
26. Immunopathogenesis and Immunogenetic Variants in COVID-19
    Pakorn Sagulkoo, Kitiporn Plaimas, Apichat Suratanee, Andréa Name Colado Simão, Edna Maria Vissoci Reiche, Michael H. J. Maes · 2022 · Current Pharmaceutical Design
27. Fluorescence‐based thermometry for precise estimation of nanoparticle laser‐induced heating in cancerous cells at nanoscale
    Oleksii O. Peltek, Агеев Эдуард Игоревич, Pavel M. Talianov, Anna D. Mikushina, Olga S. Epifanovskaya, Aliaksei Dubavik, Vadim P. Veiko, Kirill Viktorovich Lepik, Dmitry A. Zuev, Alexander S. Timin et al. · 2022 · Nanophotonics
28. Alpha-Momorcharin Inhibits Proinflammatory Cytokine Expression by M1 Macrophages but Not Anti-Inflammatory Cytokine Expression by M2 Macrophages
    Kejun Peng, Nianhua Deng, Yao Meng, Qianchuan He, Hao Meng, Ting L. Luo, Yanru Wei, Yue Jai Kang, Xiaodong Zhou, Fubing Shen · 2022 · Journal of Inflammation Research
29. Dysregulation of immunity in COVID-19 and SLE
    Seyyed Sina Hejazian, Seyyedeh Mina Hejazian, Farahnoosh Farnood, Sima Abedi Azar · 2022 · Inflammopharmacology
30. Inosine: A broad-spectrum anti-inflammatory against SARS-CoV-2 infection-induced acute lung injury via suppressing TBK1 phosphorylation
    Ningning Wang, Entao Li, Huifang Deng, Lan‐Xin Yue, Lei Zhou, Rina Su, Baokun He, Chengcai Lai, Gaofu Li, Yuwei Gao et al. · 2022 · Journal of Pharmaceutical Analysis
31. Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators
    Nusrath Yasmeen, Harikrishnan Selvaraj, Sudarshan Singh Lakhawat, Manali Datta, Pushpender Kumar Sharma, Ajay Jain, Rakhi Khanna, J Srinivasan, Vikram Kumar · 2023 · Biochemical Pharmacology
32. Serum amyloid A—A potential therapeutic target for hyper-inflammatory syndrome associated with COVID-19
    Eman M. Almusalami, Anthony Lockett, Albert Ferro, John Posner · 2023 · Frontiers in Medicine
33. Emerging roles of SARS-CoV-2 Spike-ACE2 in immune evasion and pathogenesis
    Cosima T. Baldari, Anna Onnis, Emanuele Andreano, Giuseppe Del Giudice, Rino Rappuoli · 2023 · Trends in Immunology
34. Gene Targets of CAR-T Cell Therapy for Glioblastoma
    Chaoqun Wang, Yuntao Li, Lijuan Gu, Ran Chen, Hua Zhu, Xu Zhang, Yonggang Zhang, Feng Shi, Sheng Qiu, Zhihong Jian et al. · 2023 · Cancers
35. Maternal and Neonatal Factors Modulating Breast Milk Cytokines in the First Month of Lactation
    David Ramiro‐Cortijo, Gloria Herranz Carrillo, Pratibha Singh, Miguel Rebollo‐Hernanz, Pilar Rodríguez‐Rodríguez, Santiago Ruvira, María Martín-Trueba, Camilia Rivera Martin, Silvia Magdalena Arribas · 2023 · Antioxidants
36. Long-term consequences of COVID-19 on mental health and the impact of a physically active lifestyle: a narrative review
    Leonardo Roever, Bruno Raphael Ribeiro Cavalcante, Alex Cleber Improta Caria · 2023 · Annals of General Psychiatry
37. Dysregulated pulmonary inflammatory responses exacerbate the outcome of secondary aspergillosis following influenza
    Chrono K. Lee, Lorena V. N. Oliveira, Ali Akalin, Charles A. Specht, Diana Lourenco, Christina L. Gomez, Zaida G. Ramirez‐Ortiz, Jennifer P Wang, Stuart M. Levitz · 2023 · mBio
38. COVID‐19 cooling: Nanostrategies targeting cytokine storm for controlling severe and critical symptoms
    Yu Zheng, Yuke Li, Li Mao, Rui Wang, Yuhong Jiang, Mengnan Zhao, Jun Lan Lu, Rui Li, Xiaofang Li, Sanjun Shi · 2023 · Medicinal Research Reviews
39. SARS-CoV-2 causes dysfunction in human iPSC-derived brain microvascular endothelial cells potentially by modulating the Wnt signaling pathway
    Shigeru Yamada, Tadahiro Hashita, Shota Yanagida, Hiroyuki Sato, Yukuto Yasuhiko, Kaori Okabe, Takamasa Noda, Motohiro Nishida, Tamihide Matsunaga, Yasunari Kanda · 2024 · Fluids and Barriers of the CNS
40. Setdb1 protects genome integrity in murine muscle stem cells to allow for regenerative myogenesis and inflammation
    Pauline Garcia, William Jarassier, Caroline E. Brun, Lorenzo Giordani, Fany Agostini, Wai Hing Kung, Cécile Peccate, Jade Ravent, Sidy Fall, Valentin Petit et al. · 2024 · Developmental Cell
41. Exploring the revolutionary potential of MXene nanoparticles in breast Cancer therapy: A review of applications and future prospects
    Ali Mohammad Amani, Lobat Tayebi, Ehsan Vafa, Reza Bazargan Lari, Milad Abbasi, Ahmad Vaez, Hesam Kamyab, Saravanan Rajendran, Mohammad Javad Azizli · 2025 · International Immunopharmacology
42. Microbiota as a potentially-modifiable factor influencing COVID-19
    Vu L. Ngo, Andrew T. Gewirtz · 2021 · Current Opinion in Virology
43. Posterior Reversible Encephalopathy Syndrome and brain haemorrhage as COVID-19 complication: a review of the available literature
    Francesco Motolese, Mario Nicola Vittorio Ferrante, Mariagrazia Rossi, Alessandro Magliozzi, Martina Sbarra, Francesca Ursini, Massimo Marano, Fioravante Capone, Francesco Travaglino, Raffaele Antonelli Incalzi et al. · 2021 · Journal of Neurology
44. Methotrexate as a safe immunosuppressive agent during the COVID-19 pandemic
    Zakiye Ganjei, Hoorvash Faraji Dana, Sepehr Ebrahimi‐Dehkordi, Fereshte Alidoust, Kiumars Bahmani · 2021 · International Immunopharmacology
45. Drug-Based Therapeutic Strategies for COVID-19-Infected Patients and Their Challenges
    Khatereh Zarkesh, Elaheh Entezar-Almahdi, Parisa Ghasemiyeh, Mohsen Akbarian, Marzieh Bahmani, Shahrzad Roudaki, Rahil Fazlinejad, Soliman Mohammadi‐Samani, Negar Firouzabadi, Majid Hosseini et al. · 2021 · Future Microbiology
46. Disulfiram attenuates MCMV-Induced pneumonia by inhibition of NF-κB/NLRP3 signaling pathway in immunocompromised mice
    Xiaotao Huang, Ping Sun, Yuyan Qin, Xiaojuan Wang, Mengyi Wang, Yongtong Lin, Ruiqing Zhou, Wenhui Hu, Qifa Liu, Xiyong Yu et al. · 2021 · International Immunopharmacology
47. Fibronectin as a Marker of Disease Severity in Critically Ill COVID-19 Patients
    Anna Lemańska-Perek, Dorota Krzyżanowska‐Gołąb, Barbara Dragan, Maciej Tyszko, Barbara Adamik · 2022 · Cells
48. An Evidence-Based Guideline Improves Outcomes for Patients With Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome
    Maria L. Taylor, Kacie J. Hoyt, Joseph K. Han, Leslie A. Benson, Siobhan Case, Mia T. Chandler, Margaret H. Chang, Craig D. Platt, Ezra M. Cohen, Megan Day‐Lewis et al. · 2022 · The Journal of Rheumatology
49. NSAID use and clinical outcomes in COVID-19 patients: A 38-center retrospective cohort study
    Justin Reese, Ben D Coleman, Lauren Chan, Hannah Blau, Tiffany J. Callahan, Luca Cappelletti, Tommaso Fontana, Katie R. Bradwell, Nomi L. Harris, Elena Casiraghi et al. · 2021 · medRxiv
50. Genetic control of the dynamic transcriptional response to immune stimuli and glucocorticoids at single-cell resolution
    Justyna Resztak, Julong Wei, Samuele Zilioli, Edward D. Sendler, Adnan Alazizi, Henriette E. Mair-Meijers, Peijun Wu, Xiaoquan Wen, Richard Bennett Slatcher, Xiang Zhou et al. · 2023 · Genome Research
51. Trained Decoy Nanocages Confer Selective Cuproptosis and Metabolic Reprogramming for Drug-Resistant Bacterial Targeting Therapy
    Wenting Zhang, Jiahao Hu, Huiqun Hu, Zengwen Zhang, Wanying Zhang, Huidan Lu, Xiaoyue Lei, Yifei Zeng, Jingyan Xia, Feng Xu · 2025 · ACS Nano
52. Immunoengineered mitochondria for efficient therapy of acute organ injuries via modulation of inflammation and cell repair
    Qing Zhang, Yan Shen, Chengyuan Zhang, Hanyi Zhang, Xuemei Li, Shengqian Yang, Chen Dai, Xiuyan Yu, Jie Lou, Jinwei Feng et al. · 2025 · Science Advances
53. The immune modulatory effects of umbilical cord-derived mesenchymal stromal cells in severe COVID-19 pneumonia
    Rachele Ciccocioppo, Davide Gibellini, Giuseppe Astori, Martina Bernardi, Angela Bozza, Katia Chieregato, Francesca Elice, Stefano Ugel, Simone Caligola, Francesco De Sanctis et al. · 2021 · Stem Cell Research & Therapy
54. COVID-19 and Kounis Syndrome: Deciphering Their Relationship
    Nicholas George Kounis, Ioanna C. Koniari, Cesare DE GREGORIO · 2021 · Balkan Medical Journal
55. The Clinical Significance of Procalcitonin Elevation in Patients over 75 Years Old Admitted for COVID‐19 Pneumonia
    Andrea Ticinesi, Antonio Nouvenne, Beatrice Prati, Loredana Guida, Alberto Parise, Nicoletta Cerundolo, Chiara Bonaguri, Rosalia Aloe, Angela Guerra, Tiziana Meschi · 2021 · Mediators of Inflammation
56. Lung-Centric Inflammation of COVID-19: Potential Modulation by Vitamin D
    Hana M. A. Fakhoury, Peter R. Kvietys, Ismail Mohammed Shakir, Hashim Shams, William Burgess Grant, Khaled Manae AlKattan · 2021 · Nutrients
57. Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors
    Benjamin Switzer, John B.A.G. Haanen, Paul C. Lorigan, Igor J. Puzanov, Samra Turajlic · 2021 · Journal for ImmunoTherapy of Cancer
58. Addressing the ‘hypoxia paradox’ in severe COVID-19: literature review and report of four cases treated with erythropoietin analogues
    Martin Begemann, Oliver Groß, Dominik Wincewicz, Rüdiger Hardeland, Vinícius Daguano Gastaldi, Eduard Vieta, Karin Weißenborn, Kamilla Woznica Miskowiak, Onnen Moerer, Hannelore Ehrenreich · 2021 · Molecular Medicine
59. Specific Cytokine Profiles Predict the Severity of Influenza A Pneumonia: A Prospectively Multicenter Pilot Study
    Yu Xie, Yan Yu, Lili Zhao, Pu Ning, Qiongzhen Luo, Ying Zhang, Lu Yin, Yali Zheng, Zhancheng Gao · 2021 · BioMed Research International
60. Is COVID-19-associated cytokine storm distinct from non-COVID-19 secondary hemophagocytic lymphohistiocytosis?
    Johnson M Liu, Jeffrey Chi · 2022 · Experimental Biology and Medicine
61. Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19
    Fabio Salvatore Macaluso, Alessandra Giuliano, Walter Fries, Anna Viola, Alfredo Abbruzzese, Maria Cappello, E Giuffrida, Lucio Carrozza, Antonino Carlo Privitera, Antonio Magnano et al. · 2022 · Inflammatory Bowel Diseases
62. Myocardial Injury in COVID-19 and Its Implications in Short- and Long-Term Outcomes
    Andrea Izquierdo-Marquisá, Héctor Cubero-Gallego, Álvaro Aparisi, Beatriz Vaquerizo, Núria Ribas · 2022 · Frontiers in Cardiovascular Medicine
63. Multivalent ACE2 engineering—A promising pathway for advanced coronavirus nanomedicine development
    Eugene Marfo Obeng, Isaac Fianu, Michael K. Danquah · 2022 · Nano Today
64. Chimeric antigen receptor T cell therapy for cancer: clinical applications and practical considerations
    Joseph E. Maakaron, Marie Hu, Najla El Jurdi · 2022 · BMJ
65. IFN- γ is Protective in Cytokine Release Syndrome-associated Extrapulmonary Acute Lung Injury
    Ying Hui Sun, Buqu Hu, Gail Stanley, Zachary M. Harris, Samir Gautam, Robert Homer, Jonathan L. Koff, Govindarajan Rajagopalan · 2022 · American Journal of Respiratory Cell and Molecular Biology
66. The oldest unvaccinated Covid-19 survivors in South America
    Mateus Vidigal de Castro, Moníze V. R. Silva, Michel Satya Naslavsky, Marília O. Scliar, Kelly Nunes, Maria Rita Passos‐Bueno, Erick C. Castelli, Jhosiene Yukari Magawa, Flávia Lopes Adami, Ana Iochabel Soares Moretti et al. · 2022 · Immunity & Ageing
67. Host biomarker-based quantitative rapid tests for detection and treatment monitoring of tuberculosis and COVID-19
    Louise Pierneef, Anouk van Hooij, Daniëlle de Jong, Elisa M. Tjon Kon Fat, Krista E. van Meijgaarden, Elisa Petruccioli, Valentina Vanini, Anna H.E. Roukens, Delia Goletti, Paul L. A. M. Corstjens et al. · 2022 · iScience
68. ZBP1 and heatstroke
    Fanglin Li, Jiayi Deng, Qiuli He, Yanjun Zhong · 2023 · Frontiers in Immunology
69. Revitalizing myocarditis treatment through gut microbiota modulation: unveiling a promising therapeutic avenue
    Jingyue Wang, Xianfeng Zhang, Xinyu Yang, Hang Yu, Meng-Meng Bu, Jie Fu, Zhengwei Zhang, Hui Xu, Jiachun Hu, Jin‐Yue Lu et al. · 2023 · Frontiers in Cellular and Infection Microbiology
70. A viral pan-end RNA element and host complex define a SARS-CoV-2 regulon
    Debjit Khan, Fulvia Terenzi, Guanqun Liu, Prabar Kumar Ghosh, Fengchun Ye, Kien Nguyen, Arnab China, Iyappan Ramachandiran, Shruti Chakraborty, Jennifer Stefan et al. · 2023 · Nature Communications
71. Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
    Taweegrit Siripongboonsitti, Teerapat Ungtrakul, Kriangkrai Tawinprai, Chirayu Udomsakdi Auewarakul, Wipada Chartisathian, Thitikan Jansala, Rattana Julsawad, Kamonwan Soonklang, Nithi Mahanonda, Chulabhorn Mahidol · 2023 · Phytomedicine
72. Inhaled Exosomes Genetically Manipulated to Overexpress CD24 (EXO-CD24) as a Compassionate Use in Severe ARDS Patients
    Orr Green, Gil Shenberg, Roni Baruch, Lihi Argaman, Talya Levin, Ian Michelson, Ruthy Hadary, Boris Isakovich, Miri Golos, Reut Schwartz et al. · 2023 · Biomedicines
73. Expression of IFN-Gamma is significantly reduced during severity of covid-19 infection in hospitalized patients
    Sajid Mansoor, Ayesha Raza Butt, Asima Bibi, Saima Mushtaq, Inayat Ullah, Fahad Alshahrani, Amjad Khan, Atika Mansoor · 2023 · PLoS ONE
74. Niclosamide, but not ivermectin, inhibits anoctamin 1 and 6 and attenuates inflammation of the respiratory tract
    Jiraporn Ousingsawat, Raquel Centeio, Rainer Schreiber, Karl Kunzelmann · 2023 · Pflügers Archiv - European Journal of Physiology
75. Cytokine Modification of Adoptive Chimeric Antigen Receptor Immunotherapy for Glioblastoma
    Kristen D. Pawlowski, J. Duffy, S. Gottschalk, I. Balyasnikova · 2023 · Cancers
76. Gp130–HIF1α axis–induced vascular damage is prevented by the short-term inhibition of IL-6 receptor signaling
    Sujin Kang, Shinya Onishi, Zhenzhen Ling, Hitomi Inoue, Yingying Zhang, Hao Chang, Hui Zhao, Tong Wang, Daisuke Okuzaki, Hiroshi Matsuura et al. · 2024 · Proceedings of the National Academy of Sciences
77. Longitudinal, natural history study reveals the disease burden of idiopathic multicentric Castleman disease
    Mateo Sarmiento Bustamante, Sheila K. Pierson, Yue Ren, Adam Bagg, Joshua D. Brandstadter, Gordan Srkalović, Natalie Mango, Daisy V. Alapat, Mary Jo Lechowicz, Hongzhe Li et al. · 2024 · Haematologica
78. The Systemic Score May Identify Life‐Threatening Evolution in Still Disease: Data from the GIRRCS AOSD‐Study Group and the AIDA Network Still Disease Registry
    Piero Ruscitti, Francesco Masedu, Antonio Vitale, Valeria Caggiano, Ilenia Di Cola, Paola Cipriani, Marco Valenti, Henrique Ayres Mayrink Giardini, Isabele Parente de Brito Antonelli, Marilia Ambiel Dagostin et al. · 2024 · Arthritis & Rheumatology
79. Vaccines Induce Homeostatic Immunity, Generating Several Secondary Benefits
    Balasubramanian Arunachalam · 2024 · Vaccines
80. High mortality of Acinetobacter baumannii infection is attributed to macrophage-mediated induction of cytokine storm but preventable by naproxen
    Han Wang, Qi Xu, Heng Heng, Wenxing Zhao, Hongyuhang Ni, Kaichao Chen, Bill Kwan Wai Chan, Yang Tang, Miaomiao Xie, Mingxiu Peng et al. · 2024 · EBioMedicine
81. Traumatic brain injury: Symptoms to systems in the 21st century
    Geoffrey Phillip Dobson, Jodie L. Morris, Hayley L. Letson · 2024 · Brain Research
82. Dengue virus NS1 hits hard at the barrier integrity of human cerebral microvascular endothelial cells via cellular microRNA dysregulations
    Apoorva, Atul Kumar, Sunit K. Singh · 2024 · Tissue Barriers
83. Regulation of ubiquitination in sepsis: from PAMP versus DAMP to peripheral inflammation and cell death
    Yueying Li, Jian Yu, Zhiwen Zeng, Weixiong Lin · 2024 · Frontiers in Immunology
84. Biomarkers of Cardiac Stress and Cytokine Release Syndrome in COVID-19: A Review
    Jonathan S. Gordon, Mark H. Drazner · 2021 · Current Heart Failure Reports
85. Soluble ligands as drug targets for treatment of inflammatory bowel disease
    Xuhui Tong, Yuanyuan Zheng, Yu Li, Yongjian Xiong, Dapeng Chen · 2021 · Pharmacology & Therapeutics
86. Problems of early diagnosis of systemic lupus erythematosus during the COVID-19 pandemic
    Evgeny Lvovich Nasonov, Т. В. Попкова, T. A. Panafidina · 2021 · Rheumatology Science and Practice
87. Increased efficacy of dual proinflammatory cytokine blockade on acute GVHD while maintaining GVT effects
    Lam T. Khuat, Logan Vahid Vick, Cordelia Dunai, Craig P. Collins, Shyam Kailashrao More, Catherine T. Le, Chien-Chun Steven Pai, Kevin M. Stoffel, Emanual Michael Maverakis, Robert J. Canter et al. · 2021 · Blood
88. Sources and clinical significance of aspartate aminotransferase increases in COVID-19
    Elena Aloisio, Giulia Colombo, Claudia Arrigo, Alberto Dolci, Mauro Panteghini · 2021 · Clinica Chimica Acta
89. Evaluating the relationship between myocarditis and mRNA vaccination
    Charlotte Switzer, Mark B Loeb · 2021 · Expert Review of Vaccines
90. Physiologic isolation and expansion of human mesenchymal stem/stromal cells for manufacturing of cell‐based therapy products
    Dominik Egger, Antonina V. Lavrentieva, Patrick Kugelmeier, Cornelia Kasper · 2021 · Engineering in Life Sciences
91. A Patent Review on the Therapeutic Application of Monoclonal Antibodies in COVID-19
    Syed Mohammed Basheeruddin Asdaq, Syed Imam Rabbani, Meshary Alkahtani, Meshal Meshary Aldohyan, Abdullah Mohammad Alabdulsalam, Majed Al-Shammari, Saleh Ahmad Alajlan, Aljawharah Binrokan, Yahya Ali Mohzari, Ahmed Ali Alrashed et al. · 2021 · International Journal of Molecular Sciences
92. Immunomodulation and Regenerative Capacity of MSCs for Long-COVID
    Xin Ya Loke, Siti A. M. Imran, Gee Jun Tye, Wan Safwani Wan Kamarul Zaman, Fazlina Nordin · 2021 · International Journal of Molecular Sciences
93. Comparative Study of Cytokine Storm Treatment in Patients with COVID-19 Pneumonia Using Immunomodulators
    Felicia Marc, Corina Maria Moldovan, Anica Hoza, Sorina Magheru, Gabriela Ciavoi, Dorina Maria Farcaș, Liliana Sachelarie, Gabriela Călin, Laura Ecaterina Romila, Daniela Liliana Damir et al. · 2022 · Journal of Clinical Medicine
94. A Real Pandora’s Box in Pandemic Times: A Narrative Review on the Acute Cardiac Injury Due to COVID-19
    Amalia Stefana Țimpău, Radu-Ştefan Miftode, Daniela A. Leca, Razvan Timpau, Ionela-Larisa Miftode, Antoniu Octavian Petriş, Irina Iuliana Costache, Ovidiu Mitu, Ana Nicolae, Alexandru Florinel Oancea et al. · 2022 · Life
95. Improving Diagnosis and Clinical Management of Acquired Systemic Autoinflammatory Diseases
    Adam Al‐Hakim, Anoop Mistry, Sinisa Savic · 2022 · Journal of Inflammation Research
96. Association of Serum Ferritin Levels and Methylprednisolone Treatment With Outcomes in Nonintubated Patients With Severe COVID-19 Pneumonia
    Aikaterini Papamanoli, Andreas P. Kalogeropoulos, Jessica Hotelling, Jeanwoo Yoo, Prabhjot K. Grewal, William Predun, Robin Jacob, Kerry Cao, Luis A. Marcos, Hal A. Skopicki · 2021 · JAMA Network Open
97. Vagal nerve stimulation for the management of long COVID symptoms
    Malik Waleed Zeb Khan, Muhammad Ahmad, Salma Qudrat, Fatma Afridi, Najia Ali Khan, Zain Afridi,  Fahad, Touba Azeem, Jibran Ikram · 2024 · Infectious Medicine
98. Bronchoalveolar lavage single-cell transcriptomics reveals immune dysregulations driving COVID-19 severity
    Clinton Njinju Asaba, Razieh Bitazar, Patrick Labonté, Terence Ndonyi Bukong · 2025 · PLoS ONE
99. Iron—sepsis associations in population health revealed by epidemiology
    Randi Marie Mohus, Lise Tuset Gustad, Jan Kristian Damås, Hal Drakesmith · 2025 · EBioMedicine
100. Immunological Interfaces: The COVID-19 Pandemic and Depression
     Austin Perlmutter · 2021 · Frontiers in Neurology